Core & Main misses profit expectations, sees 'pockets of softness' in new projects
Shares of Core & Main Inc. (CNM) slumped 2.0% in premarket trading Wednesday, after the provider of water, storm drainage and fire protection products and services to contractors and municipalities missed fiscal second-quarter profit expectations and trimmed its full-year sales growth outlook, citing "pockets of weakness" in new projects. Net income for the quarter to July 30 slipped to $110 million, or 66 cents a share, from $115 million, or 67 cents a share, in the year-ago period, to miss the FactSet consensus for earnings per share of 67 cents. Sales were flat at $1.86 billion, in line with expectations, as acquisitions and higher selling prices were offset by lower volume. For fiscal 2023, the company lowered its sales guidance range to $6.6 billion to $6.8 billion from $6.6 billion to $6.9 billion, compared with the current FactSet consensus of $6.7 billion. "Pricing and margins are sustaining against improving supply chains, but we are beginning to see pockets of softness for new non-residential project starts in select markets," said Chief Executive Steve LeClair. The stock, which closed at a record high $33.02 on Aug. 30, has climbed 12.4% over the past three months through Tuesday, while the S&P 500 has gained 5.0%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-06-23 0822ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks